CCP 01 - Hemostemix
Alternative Names: Cardiomyocyte cell precursors - Hemostemix; CCP-01 - HemostemixLatest Information Update: 27 Mar 2025
At a glance
- Originator Hemostemix
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hypertrophic cardiomyopathy
- Research Myocardial infarction